Automated Blood Processing Equipment Market Outlook:
Automated Blood Processing Equipment Market size was valued at USD 4.5 billion in 2025 and is projected to reach USD 9.1 billion by the end of 2035, rising at a CAGR of 7.4% during the forecast period 2026 to 2035. In 2026, the industry size of automated blood processing equipment is estimated at USD 4.8 billion.
The automated blood processing equipment market is supported by sustained growth in blood collection, transfusion services, and component preparation programs across public health systems. According to the World Health Organization (WHO) June 2024 data, approximately 118.5 million blood donations are collected globally each year, creating a substantial operational requirement for high-throughput processing, separation, testing, and storage workflows. WHO also reports that more than 40% of the world’s donated blood is collected in high-income countries that represent only about 16% of the global population, highlighting the concentration of advanced blood service infrastructure and continued investment in processing efficiency.
Government-supported blood safety initiatives and quality management requirements are also contributing to equipment modernization. The U.S. Food and Drug Administration (FDA) maintains extensive regulatory oversight of blood collection and processing establishments, reinforcing demand for technologies that support compliance, documentation, and process control. WHO estimates 129 countries report collecting millions of donations annually and have proper national guidelines on the use of blood, creating a broad installed base requiring ongoing upgrades and replacement cycles. The market therefore benefits from a combination of stable clinical demand, regulatory oversight, and healthcare system efforts to improve operational efficiency, making automated processing equipment a strategic procurement category for blood banks, national transfusion services, and hospital-based collection and processing facilities.
Key Automated Blood Processing Equipment Market Insights Summary:
Regional Highlights:
- North America is anticipated to capture 42.3% of the automated blood processing equipment market by 2035, supported by the transition toward fully automated closed systems and the consolidation of blood processing centers
- Asia Pacific is projected to witness the fastest growth in the market throughout 2026-2035, bolstered by government-led blood safety initiatives, expanding automated blood banking infrastructure, and rising demand for platelet and plasma components
Segment Insights:
- The automated blood processing equipment market is expected to see the Automatic Blood Separator sub-segment account for 56.8% of the market by 2035, driven by its ability to efficiently separate whole blood into individual components through advanced automated processing technologies
- Centrifugation-based Systems are forecast to maintain a leading position during 2026-2035, underpinned by their high throughput, proven reliability, and efficient large-volume blood component separation
Key Growth Trends:
- Increasing Surgical Procedures
- Aging populations and chronic disease burden
Major Challenges:
- High capital investment for R&D
- Stringent regulatory approval processes
Key Players: Terumo BCT (U.S.), Fresenius Kabi (Germany), Grifols (Spain, Europe), LivaNova (UK), Nipro Corporation (Japan), Haemonetics Corporation, Abbott Laboratories,
Global Automated Blood Processing Equipment Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 4.5 billion
- 2026 Market Size: USD 4.8 billion
- Projected Market Size: USD 9.1 billion by 2035
- Growth Forecasts: 7.4% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (42.3% share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, China, Canada
- Emerging Countries: India, Malaysia, Indonesia, South Korea, Australia
Last updated on : 22 June, 2026
Automated Blood Processing Equipment Market - Growth Drivers and Challenges
Growth Drivers
- Increasing Surgical Procedures: Government healthcare systems continue expanding surgical capacity, increasing demand for blood components and associated processing equipment. WHO September 2023 data estimates that more than 300 million major surgical procedures are performed worldwide annually. National health agencies are also investing heavily in trauma systems and emergency preparedness. Increased surgical volumes translate into greater demand for red blood cells, platelets, and plasma products, requiring efficient blood processing operations. Countries expanding universal healthcare access are seeing growth in elective and emergency procedures, which places additional pressure on blood banks. Consequently, healthcare authorities and public hospitals increasingly procure automation technologies that can improve throughput while ensuring consistent blood component quality and traceability.
- Aging populations and chronic disease burden: Population aging is increasing transfusion requirements and creating sustained demand for blood processing infrastructure. According to the United Nations 2023 data, the number of people aged 65 years and older is projected to exceed 1.5 billion globally by 2050. Older populations have higher rates of cardiovascular disease, cancer, orthopedic surgeries, and chronic conditions that frequently require transfusion support. Governments are allocating larger healthcare budgets to address age-related disease burdens, resulting in expanded hospital and transfusion services. Automated blood processing equipment helps healthcare systems manage rising demand while controlling labor costs and maintaining quality standards.
Challenges
- High capital investment for R&D: Developing automated blood processing systems requires substantial investment in precision engineering, sterile manufacturing facilities, and regulatory compliance testing. Small entrants struggle to match the R&D budgets of established players like Terumo BCT or Fresenius Kabi. The need for cleanrooms, specialized molds for disposables, and validation studies creates high entry barriers. Many startups seek partnerships or venture funding to overcome this hurdle.
- Stringent regulatory approval processes: Automated blood processing equipment falls under Class II or III medical device regulations requiring FDA 510(k) or PMA approval in the USA and CE marking in Europe. The lengthy, multi-phase validation process delays market entry by several years. Companies must provide extensive clinical evidence of safety and efficacy. This complexity discourages smaller innovators, favoring large corporations with dedicated regulatory affairs teams.
Automated Blood Processing Equipment Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
7.4% |
|
Base Year Market Size (2025) |
USD 4.5 billion |
|
Forecast Year Market Size (2035) |
USD 9.1 billion |
|
Regional Scope |
|
Automated Blood Processing Equipment Market Segmentation:
Product Type Segment Analysis
Under the product type segment, the automatic blood separator sub segment is leading and is poised to hold the share value of 56.8% by the end of 2035. The segment is fueled as it is capable of removing the blood components from the whole blood. Innovations in automated blood separation systems now include acoustofluidic platforms that process undiluted whole blood in a single step, removing red cells, white cells, and platelets simultaneously—unlike conventional centrifugation requiring multiple steps. According to the NLM June 2024 study, this method leverages differences in acoustic impedances to generate greater forces on suspended particles, achieving >90% removal of cellular components at low voltages (25 Vpp). Traditional centrifugation, while the gold standard, can activate and fragment platelets, altering extracellular vesicle profiles. The acoustofluidic approach preserves plasma proteins and antibodies, offering portability, cost efficiency, and small-volume processing.
Component Separation Technology Segment Analysis
Centrifugation-based systems dominate the component separation technology segment due to their proven reliability, high throughput, and ability to process large volumes of whole blood efficiently. These automated systems utilize centrifugal force to separate blood into its core components—red blood cells, platelets, and plasma—based on differences in density. Their scalability makes them suitable for both centralized blood banks and hospital-based transfusion centers. Additionally, centrifugation maintains cellular integrity better than some alternative technologies, preserving platelet function and plasma protein quality. These operational advantages, combined with lower consumable costs per unit processed, ensure centrifugation remains the preferred technology for automated blood processing globally.
End user Segment Analysis
Blood banks and transfusion centers represent the largest end-user sub-segment in the automated blood processing equipment market, driven by centralized processing of donor blood. According to the PIB March 2022 data, the presence of 3,840 licensed blood banks in a single country underscores why blood banks and transfusion centers are leading in the automated blood processing equipment market. Each licensed facility requires automated blood processing equipment to separate whole blood into components, ensure pathogen reduction, and meet regulatory standards. With both government and private blood banks operating in parallel, the need for scalable, high-throughput automation becomes critical to reduce manual errors and improve traceability. As regulatory bodies mandate stricter quality controls, these thousands of licensed blood banks increasingly adopt next-generation automated processors, solidifying their dominant revenue position.
Our in-depth analysis of the automated blood processing equipment market includes the following segments:
|
Segment |
Subsegments |
|
Product Type |
|
|
Component Separation Technology |
|
|
End user |
|
|
Application |
|
|
Automation Level |
|
|
Modality |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Automated Blood Processing Equipment Market - Regional Analysis
North America Market Insights
North America is dominating the automated blood processing equipment market and is expected to hold the regional revenue share of 42.3% by the end of 2035. The region is characterized by a mature regulatory framework and a high concentration of licensed blood centers. The United States and Canada both maintain stringent quality standards enforced by federal health agencies and accreditation bodies. Blood establishments in the region increasingly transition from semi-automated to fully automated closed systems to enhance component consistency and reduce manual handling errors. Consolidation of smaller blood banks into centralized processing hubs drives demand for high-throughput automated separators. Additionally, aging donor demographics push operators to maximize yields from each whole blood donation.
The strong regulatory framework and growing clinical demand for blood components is shaping the automated blood processing equipment market in the U.S. The U.S. Food and Drug Administration in February 2025 has issued guidance recommending the use of FDA-cleared automated blood cell separators for the collection of single and double units of red blood cells through automated apheresis methods, reinforcing the role of automation in blood establishments and transfusion services. Demand is further strengthened by the rising burden of cancer care. According to the NLM February 2025 study, the U.S. is projected to record 2,041,910 new cancer cases and 618,120 cancer deaths in 2025, increasing requirements for transfusions, platelet support, and blood component processing across hospitals and specialized treatment centers.
The growing healthcare demand associated with population growth and aging demographics, both of which increase requirements for transfusion services, blood component preparation, and hospital-based treatment is driving the automated blood processing equipment market in Canada. According to Government of Canada June 2024 data, Canada’s population surpassed 41.5 million in 2024, expanding the potential patient base requiring surgical, oncology, and chronic disease care. Government of Canada September 2024 data also reported that approximately 7.8 million Canadians were aged 65 years and older in 2024, representing a population segment with higher utilization of blood transfusions and related medical procedures. These demographic trends are encouraging hospitals, blood collection organizations, and healthcare facilities to invest in automated processing systems that improve operational efficiency, throughput, and quality management.
APAC Market Insights
The Asia Pacific is projected to emerge as the fastest growing region during the assessed period, 2026 to 2035 in the automated blood processing equipment market. The region is shaped by rapidly modernizing blood transfusion services across both mature and emerging economies. Countries such as Japan, South Korea, and Australia have well-established automated processing networks, while India, Malaysia, and Indonesia are actively transitioning from manual to semi-automated and fully automated systems. Government-led blood safety initiatives and centralization of blood banks into regional hubs drive procurement of high-throughput separators. Growing demand for platelet and plasma components for therapeutic use further accelerates automation adoption. Local manufacturing partnerships and technology transfer agreements help suppliers penetrate cost-sensitive markets. Diverse regulatory landscapes require tailored compliance strategies for each country.
The adoption of intelligent blood collection technologies in major healthcare institutions is driving the automated blood processing equipment market in China. The NLM September 2023 study conducted at Zhongshan Hospital, Fudan University, evaluated an NMPA-approved intelligent venipuncture and blood collection robot and found a 94.3% puncture success rate among users, demonstrating the operational feasibility of automated blood collection in clinical settings. Additionally, the technology was assessed across 6,255 patients between September 2021 and August 2022, providing substantial real-world evidence of its application in routine healthcare workflows. Supported by China's focus on healthcare digitalization and medical device innovation, hospitals are increasingly evaluating automated blood collection and processing systems to improve specimen quality, workflow standardization, and patient experience.
The expansion and modernization of the country’s blood transfusion network is shaping the automated blood processing equipment market in India. According to the Directorate General of Health Services December 2024 data, Ministry of Health and Family Welfare, India has 4,263 licensed blood centers operating across government, charitable, NGO, and private sectors, creating substantial demand for efficient blood processing and management technologies. Government support also extends to 1,131 public and charitable blood banks through manpower assistance, blood bags, testing kits, and mobile blood collection units. Furthermore, during the Raktdaan Amrit Mahotsav 2022 campaign, India collected 271,574 units of blood through voluntary donation drives, highlighting the growing scale of blood collection activities and the need for advanced automated processing solutions.
Europe Market Insights
The automated blood processing equipment market in Europe is characterized by harmonized regulatory standards under EU medical device regulations, alongside diverse national blood service structures. Western European countries such as Germany, France, and the UK operate centralized, high-volume blood processing facilities with advanced automation, while Eastern European nations continue modernizing legacy systems. Stringent quality and traceability requirements from European Directorate for the Quality of Medicines drive demand for closed-system automated separators. Cross-border blood component sharing agreements encourage standardized equipment adoption. Replacement cycles and technology upgrades to incorporate pathogen reduction capabilities sustain steady demand.
The automated blood processing equipment market in Germany is supported by strong blood donation activity and a high volume of complex surgical procedures. According to the WHO 2025 data, Germany collected 3.67 million whole blood donations in 2023, making it one of Europe’s largest blood collection markets and creating substantial demand for automated blood processing and component separation systems. In addition, data from the NLM December 2025 study show that 103,617 heart surgery procedures were performed in 2023, highlighting the significant need for blood products in specialized clinical care. These factors continue to drive investments in automated technologies that improve processing efficiency, traceability, and blood component quality.
The sustained blood collection activity and increasing demand for transfusion-dependent healthcare services is shaping the automated blood processing equipment market in the UK. According to NLM April 2024 study, the organization issued approximately 1.7 million units of blood components to hospitals in England, underscoring the need for efficient blood processing and inventory management systems. Additionally, data from Wiltshire Intelligence 2023, based on official national statistics, indicate that there are approximately 385,000 new cancer cases diagnosed annually in the UK. The growing requirement for blood transfusions in oncology, surgery, and critical care is encouraging blood centers and healthcare providers to invest in automated processing technologies that improve component quality, throughput, and operational consistency across the national transfusion network.
Key Automated Blood Processing Equipment Market Players:
- Terumo BCT (U.S.)
- Fresenius Kabi (Germany)
- Grifols (Spain, Europe)
- LivaNova (UK)
- Nipro Corporation (Japan)
- Haemonetics Corporation
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Terumo BCT is a dominant force in the automated blood processing equipment market, offering integrated systems for blood collection, component separation, and pathogen reduction. The company’s strategic initiatives include developing the Reveos® automated processing system, which enhances efficiency and consistency in whole blood processing.
- Fresenius Kabi is leading in the automated blood processing equipment market and leverages its expertise in transfusion medicine and cell therapy. The company provides automated devices like the Fresenius Com.Tec® system for blood bag assembly and sealing, alongside advanced apheresis platforms. in 2024, the company has earned a revenue of 21,526 million euro.
- Grifols has established a stronghold in the automated blood processing equipment market through its comprehensive “end-to-end” solutions for blood fractionation and donor management. The company’s strategic initiatives center on integrating automated blood processing with digital platforms like the Grifols plasma management system.
- LivaNova actively participates in the automated blood processing equipment market primarily through its perfusion and autotransfusion systems used in cardiac surgery. The company’s strategic initiatives include developing next-generation autologous blood recovery devices, such as the Xtra® Autotransfusion System, which automates the washing and reinfusion of shed blood.
- Nipro Corporation is a key Asian player in the automated blood processing equipment market, offering automated blood bag systems, separator devices, and apheresis equipment. Strategically, Nipro emphasizes compact, high-efficiency processors designed for the growing demands of blood centers in Asia and beyond. In 2024, the company’s net sales increased by 9.9%.
Here is a list of key players operating in the global automated blood processing equipment market:
The automated blood processing equipment market is highly competitive, characterized by the presence of established multinational corporations and innovative regional players. Key strategic initiatives include continuous R&D for advanced closed-loop systems, geographic expansion into emerging economies, and regulatory approvals for pathogen reduction technologies. Leading companies focus on mergers and acquisitions to consolidate product portfolios and enhance automation for blood component separation and whole blood processing. Partnerships with blood banks and hospitals are also prevalent to secure long-term contracts. The automated blood processing equipment market is driven by the rising demand for safe blood transfusions and operational efficiency, pushing players toward digital integration and user-friendly devices.
Corporate Landscape of the Automated Blood Processing Equipment Market:
Recent Developments
- In December 2024, Haemonetics Corporation focused on delivering innovative medical solutions to drive better patient outcomes, announced that it has entered into a definitive agreement to sell its whole blood assets to GVS, S.p.A. The transaction comprises a total cash consideration of up to USD 67.1 million, which includes USD 44.6 million upfront and up to USD 22.5 million in contingent earn-outs over the next four years.
- In October 2024, Terumo Blood and Cell Technologies announced the launch of the Reveos™ Automated Blood Processing System in the U.S. to help blood centers meet blood and platelet supply needs while helping their staff work more efficiently.
- In April 2024, Grifols, the world’s leading producer of plasma-derived medicines and innovative diagnostic solutions, announced the launch of its leading blood-typing technology – the fully automated Erytra Eflexis – in the Chinese market following regulatory approval.
- Report ID: 5922
- Published Date: Jun 22, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
About this Report
Connect with our Expert
Report, 2026-2035
Copyright @ 2026 Research Nester. All Rights Reserved.
